EUVIMEDScopri EUVIMED
Crossref

Self‐Micellizing Solid Dispersion of Silibinin With Improved Oral Absorption and Hepatoprotective Effects

Sujan Banik iD, Shoma Ueda, Kohei Yamada iD, Hideyuki Sato iD, Satomi Onoue iD

Biopharmaceutics & Drug Disposition · 2026-11-13

DOI: 10.1002/bdd.70040 ↗

At a glance

Journal article in Biopharmaceutics & Drug Disposition, published online on 2026-11-13. Written by Sujan Banik and 4 co-authors. Institution: Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan. 44 references. Funded by: JSPS KAKENHI.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

This study aimed to develop a silibinin (SIL)‐loaded self‐micellizing solid dispersion (SMSD) with improved oral absorbability and hepatoprotective properties. A suitable polymeric carrier for the development of the SMSD system was selected based on the apparent solubility of SIL in aqueous solutions of various polymers. SIL‐based SMSD (SMSD/SIL) formulations with various SIL ratios (2.5%–50% w/w) employing poloxamer 407, an amphiphilic block copolymer, were prepared via lyophilization to determine a suitable SIL‐to‐polymer ratio in SMSD systems. Among the tested formulations, SMSD/SIL, with a drug loading of 5%, significantly improved the dissolution behavior of SIL as evidenced by 30‐fold higher dissolution than crystalline SIL. The formation of uniform fine micelles, with an average diameter of 45.8 nm after dispersion in water, could improve the dissolution properties of SMSD/SIL. Rats orally administered SMSD/SIL (50 mg‐SIL/kg) exhibited enhanced oral absorption of SIL by 5.2‐fold compared with crystalline SIL. In a rat model of acute hepatic injury, repeated treatment with SMSD/SIL (50 mg‐SIL/kg/day for 2 days) attenuated hepatic damage as evidenced by histological observations and decreased hepatic biomarker levels. Based on these findings, the SMSD approach may be an effective strategy for enhancing the nutraceutical properties of SIL.

Subjects

Author keywords

dissolutionhepatoprotectionoral absorptionself‐micellizing solid dispersionsilibinin

Authors and institutions

  • Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan.

ORCID profiles: Sujan Banik, Kohei Yamada, Hideyuki Sato, Satomi Onoue

Funding

  • JSPS KAKENHI

Cite

APA

Banik, S., Ueda, S., Yamada, K., Sato, H., & Onoue, S. (2026). Self‐Micellizing Solid Dispersion of Silibinin With Improved Oral Absorption and Hepatoprotective Effects. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70040

Vancouver

Banik S, Ueda S, Yamada K, Sato H, Onoue S. Self‐Micellizing Solid Dispersion of Silibinin With Improved Oral Absorption and Hepatoprotective Effects. Biopharmaceutics & Drug Disposition. 2026. doi:10.1002/bdd.70040

BibTeX
@article{Banik2026,
  author = {Banik, Sujan and Ueda, Shoma and Yamada, Kohei and Sato, Hideyuki and Onoue, Satomi},
  title = {Self‐Micellizing Solid Dispersion of Silibinin With Improved Oral Absorption and Hepatoprotective Effects},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2026},
  doi = {10.1002/bdd.70040}
}
Start for free →